Home » Healthcare » POC Molecular Diagnostics Market

POC Molecular Diagnostics Market By Technology (PCR-based, Genetic Sequencing-based, Hybridization-based, Microarray-based) By Application Type (Infectious Diseases, HIV POC, Clostridium difficile POC, HBV POC, Pneumonia or Streptococcus associated infections, Respiratory syncytial virus (RSV) POC, HPV POC)-Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Published: | Report ID: 20566 | Report Format : PDF

Actionable Insights Delivered -POC Molecular Diagnostics Market Size

Positioned with a USD 6.9 billion valuation in 2022, the POC Molecular Diagnostics Market asserted its global eminence. Set to scale to USD 8.6 billion by 2030, the market’s remarkable Compound Annual Growth Rate (CAGR) of 3.3% (2022-2030) underscores its strategic growth trajectory.

Key Highlights of the Report

The global POC molecular diagnostics market is segmented by technology, test location, application type, end-use, and region. PCR-based and hospitals catgeories are the most widely used, while infectious diseases is a widely utilized segment. POC is the most commonly used. North America is leading the market growth.

The growing need for quick and precise diagnostic testing in distant or resource-constrained areas, the rising prevalence of infectious diseases, and the requirement for early identification and intervention drive the POC molecular diagnostics market. The high cost of creating and deploying POC molecular diagnostic technologies is a market barrier that may prevent their widespread adoption, particularly in low-income areas.

Nonetheless, the global POC molecular diagnostics market and the developments in downsizing and portable diagnostic equipment, which enable greater accessibility and convenience for point-of-care testing, represent two prospects for the POC molecular diagnostics industry. Additionally, telemedicine, digital health technologies, and POC molecular diagnostics integration offer remote monitoring, data sharing, and individualized healthcare management opportunities.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

What Are The Main Drivers Of The Global POC Molecular Diagnostics Market?

In emergency and critical care settings, as well as in distant or resource-constrained places where access to centralized laboratories may be limited, there is a rising need for speedy and trustworthy diagnostic results.

What Are The Major Challenges Faced By The Global POC Molecular Diagnostics Market?

POC molecular diagnostic device development and commercialization require navigating through complex regulatory routes, such as gaining required approvals and complying with quality and safety requirements, which can present difficulties and postpone the market launch.

What Are The Growth Opportunities In The Global POC Molecular Diagnostics Market?

In emerging markets, where healthcare infrastructure and access to diagnostics are expanding, there is a considerable possibility for market expansion. POC molecular diagnostics can help reduce the burden of infectious illnesses and enhance patient outcomes in these areas.

Executive Summary

Overview of the Global POC Molecular Diagnostics Market

The demand for quick and precise diagnostic testing in various healthcare settings drives considerable growth in the global POC molecular diagnostics market. POC molecular diagnostics have the benefit of providing fast results, allowing for prompt treatment choices and better patient outcomes. Infectious disease prevalence is rising, demanding early detection and intervention, driving the market. The high cost of creation and implementation, as well as complex regulatory requirements, present difficulties. However, there are encouraging chances for market growth in developing nations and through a combination with digital health technology, allowing for remote monitoring and individualized healthcare management. In general, the market is well-positioned for future expansion and innovation.

Market Definition

Point-of-care molecular diagnostics, also known as POC (Point-of-Care), applies molecular techniques and technology for quick and on-site testing of various diseases or ailments at the point of care, such as clinics, hospitals, or even remote sites. It entails discovering and examining certain genetic material, such as DNA or RNA, to locate infections, genetic variants, or other disease-related biomarkers. POC molecular diagnostics use a range of molecular biology procedures, including PCR, genetic sequencing, hybridization, or microarray-based approaches. These tests eliminate the need for sending samples to centralized laboratories and allow healthcare providers to get quick and accurate findings, frequently within minutes to a few hours. Particularly in environments with limited access to laboratory equipment or emergency scenarios where prompt answers are vital, POC molecular diagnostics serve a crucial role in the rapid diagnosis, treatment choices, and monitoring of diseases.

POC Molecular Diagnostics Market

Market Insights

  • The global demand for POC molecular diagnostics was valued at USD 6.9 Billion in 2022 and is expected to reach USD 8.6 Billion in 2030, growing at a CAGR of 3.3% between 2023 and 2030.
  • The PCR-based is the market leader in the technology and holds over 30% of the market’s value in 2022, while the genetic sequencing-based is anticipated to show the quickest CAGR over the forecast period,
  • The infectious diseases segment governs the global demand for POC molecular diagnostics, holding a massive share of over 8% in 2022, and is expected to grow at a rapid CAGR.
  • POC is the market leader in application type, holding over 70% of the market’s value in 2022.
  • The hospitals segment governs the global demand for POC molecular diagnostics, holding a massive share of over 45% in 2022, and is expected to grow at a rapid CAGR.
  • North America is fueling the growth of the POC molecular diagnostics industry with over one-third share in 2022. North America and Europe collectively accounted for just under 40% share in 2022. Asia Pacific held over 22% share in 2022.
  • Because of its strong laboratory networks and dense concentration of healthcare facilities, North America has a well-developed healthcare infrastructure that makes POC molecular diagnostics useable and effective.
  • The growing demand for decentralized and quick diagnostic testing drives the POC molecular diagnostics market, driven by the requirement for prompt and reliable results in critical care settings or remote areas. One market limitation is the need to comply with strict quality standards and regulatory regulations, which can present difficulties and delays in product development and market launch. Another is the complex regulatory environment.

Segmentation by Technology

  • PCR-based is the leading segment by technology and held over 45% share in value in 2022.
  • The genetic sequencing-based segment will likely exhibit the fastest CAGR during the forecast period.

Segmentation by Application Type

  • The infectious diseases segment governs the global demand for POC molecular diagnostics, holding a massive share of over 8% in 2022, and is also expected to grow at a rapid CAGR.
  • Oncology contributes to the rest of the demand for POC molecular diagnostics.

Segmentation by Test Location

  • POC application type is the leading segment by application type, holding over 70% share in value in 2022.
  • The OTC segment will likely exhibit the fastest CAGR during the forecast period.

Segmentation by End Use

  • The hospitals segment governs the global demand for POC molecular diagnostics, holding a massive share of over 45% in 2022, and is also expected to grow at a rapid CAGR.
  • The assisted living healthcare facilities segment contributes to the rest of the demand for POC molecular diagnostics.

Segmentation by Region

  • North America is fueling the growth of the POC molecular diagnostics industry with over one-third share in 2022.
  • Europe and Asia Pacific collectively account for just under 40% share in 2022, with Europe holding over 22% share in the same year.
  • The rest of the World, including Latin America, The Middle East, and Africa, contributes the remainder to the demand for POC molecular diagnostics.

The increasing prevalence of infectious diseases worldwide drives the POC molecular diagnostics market. It increases the need for quick and precise diagnostic testing at the point of care. The benefit of early detection, prompt treatment, and efficient disease management provided by POC molecular diagnostics propels their market adoption.

The POC molecular diagnostics industry is heavily used in the US to enhance patient care and disease management. POC molecular diagnostic assays are frequently used to quickly and accurately diagnose infectious diseases at the point of care, including HIV, hepatitis, and respiratory infections. These tests are frequently utilized in various healthcare settings, such as hospitals, clinics, and community health centers, enabling medical professionals to decide on the best course of therapy swiftly. POC molecular diagnostics are also used in oncology, where they help identify certain genetic alterations and direct the development of individualized treatment plans. Technological improvements, a strong healthcare infrastructure, and a focus on providing effective and patient-centered treatment are driving the industry in the United States.

The utilization of the POC molecular diagnostics market is expanding in India, especially as it relates to tackling the problems posed by infectious illnesses and enhancing access to healthcare in rural and underserved areas. For the quick identification of diseases like tuberculosis (TB) and drug-resistant TB, POC molecular diagnostic tests are used. This aids in early detection and the start of the right therapy. These tests also screen for and treat diseases like HIV and hepatitis, advancing public health programs. India’s market is driven by the demand for cost-effective, decentralized testing solutions that target underserved communities. POC molecular diagnostics are essential for expanding diagnostic capabilities to settings with low resources and advancing national disease control initiatives.

Increasing Demand For Rapid And Accurate Diagnostic Testing

The increased demand for quick and precise diagnostic tests is the primary factor driving the POC molecular diagnostics market. Both healthcare professionals and patients are looking for quicker, more accurate, and time-efficient diagnostic solutions. POC molecular diagnostics offers on-site testing with rapid turnaround times to address this need, eliminating the need to send samples to centralized laboratories.

POC molecular diagnostics allow medical personnel to decide on treatments quickly, especially in critical care settings or circumstances that call for fast actions. For instance, in situations involving sepsis or respiratory infections, prompt and accurate identification of the microorganisms responsible for the infection helps direct the use of the proper antibiotics, lowering the risk of sequelae and enhancing patient outcomes.

Rising Prevalence Of Chronic Diseases And Genetic Disorders

The increased cases of chronic illnesses and genetic abnormalities is another important factor driving the POC molecular diagnostics industry. Globally, chronic diseases like diabetes, cardiovascular disease, and cancer present considerable healthcare challenges. Early identification, monitoring, and individualized treatment methods for various illnesses are made possible by POC molecular diagnostics.

There are also many genetic problems, such as hereditary conditions and genetic variants linked to diseases. POC molecular diagnostics enable early diagnosis and targeted therapies by detecting particular genetic markers. For instance, POC molecular diagnostics in prenatal testing enable the diagnosis of genetic abnormalities in babies, assisting in making well-informed decisions regarding the management of pregnancy.

The rising frequency of chronic diseases and genetic disorders drives a growing demand for affordable and effective diagnostic options. By offering quick and accurate testing at the point of care and minimizing the time and expense involved in sending samples to centralized laboratories, POC molecular diagnostics meet this need. This method enables prompt intervention, individualized treatment programs, and better patient outcomes.

Meeting Complicated Regulatory Requirements

The difficulty of meeting complicated regulatory requirements and the obligation to adhere to exacting quality standards limit the market for POC molecular diagnostics. It requires navigating numerous regulatory processes, gaining approvals, and assuring adherence to regulatory requirements to develop and commercialize POC molecular diagnostic equipment. The time and resources required for the regulatory processes might cause delays in product development and market entrance.

The requirements for clinical validation and evidence production to prove the precision and dependability of POC molecular diagnostics can further increase the price and duration of time needed to commercialize these technologies. Companies in this industry have difficulties due to the complex regulatory environment, which limits the accessibility and general use of POC molecular diagnostic technology.

Expansion In Emerging Markets

Expanding into emerging markets represents a major POC molecular diagnostics market opportunity. These areas have substantial growth potential due to their evolving healthcare infrastructure and increased demand for better diagnostic tools. Accessible and reasonably priced diagnostic options are becoming more and more necessary as healthcare systems in developing nations continue to improve.

POC molecular diagnostics are suited for resource-constrained settings and remote locations with limited access to centralized laboratories because they give the advantage of quick and accurate testing. Companies that can adapt their products to fit the unique requirements of emerging economies, including affordability, usability, and flexibility to local illness profiles, have the potential to enter these markets and meet unmet diagnostic needs.

Integration With Digital Health Technologies

The POC molecular diagnostics industry offers integration with digital health technology as another noteworthy possibility. POC molecular diagnostics’ integration with digital health tools, including connectivity, data analytics, and telemedicine, creates new opportunities for remote monitoring, data sharing, and the management of individualized healthcare.

POC molecular diagnostic devices can convey real-time test results, patient data, and treatment suggestions to healthcare practitioners by including connectivity elements. In particular, this supports remote patient monitoring for chronic conditions and allows for effective data-driven decision-making. Additionally, by integrating with data analytics platforms, enormous amounts of diagnostic data can be collected and analyzed, providing information on illness trends, treatment effectiveness, and population health management.

POC molecular diagnostics and digital health technologies work together to improve accessibility, coordinate care better, and create more proactive, patient-centered healthcare delivery models. Businesses that take advantage of this chance can position themselves at the forefront of the healthcare industry’s digital revolution and foster innovation in POC molecular diagnostics.

Competitive Landscape

Key Players

The global POC molecular diagnostics market is highly competitive, with several key players. Some of the major players in the market and their market share are as follows:

  • Abbott
  • Bayer AG
  • F. Hoffmann-La Roche AG
  • Nova Biomedical
  • QIAGEN
  • Nipro Diagnostics
  • Danaher
  • Bio-Rad Laboratories, Inc.
  • bioMérieux
  • Agilent Technologies, Inc.
  • Abaxis
  • OraSure Technologies

The POC molecular diagnostics market has a competitive environment that is defined by the presence of both well-established competitors and up-and-coming businesses. Key industry players concentrate on product innovation, strategic alliances, and global expansion to obtain a competitive edge. Companies are competing to create cutting-edge and approachable POC molecular diagnostic solutions to address the rising need for quick and precise testing in this dynamic and fiercely competitive sector.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Summary of Key Findings

  • The PCR-based method is the technology’s market leader and will account for over 30% of the market’s value in 2022, while genetic sequencing-based methods are expected to grow at the fastest rate over the forecast period.
  • With a significant market share of over 8% in 2022 and projections of strong CAGR growth, the infectious diseases segment will likely continue dominating the global demand for POC molecular diagnostics.
  • POC is the market leader in application type and will account for over 70% of market revenue in 2022.
  • The hospital market, which will continue to dominate POC molecular diagnostics demand globally, with a significant share of over 45% in 2022, is anticipated to expand at a quick CAGR.
  • North America will account for almost one-third of the global market for POC molecular diagnostics in 2022. In 2022, the combined share of North America and Europe was a little under 40%. In 2022, Asia Pacific owned a share of over 22%.

Future Outlook

  • The POC molecular diagnostics market has bright prospects.
  • Due to the rising incidence of infectious diseases, the need for early detection and tailored medicine, and the development of digital health technology, the demand for quick and reliable diagnostic testing is predicted to keep rising.
  • More advancements in downsizing, automation, and connectivity are projected in the industry, making POC molecular diagnostic products more practical and available.
  • Future market expansion and effects on patient care are also anticipated, as are the penetration of emerging markets and integration with healthcare systems.

Segmentation

  • By Technology
    • PCR-based
    • Genetic Sequencing-based
    • Hybridization-based
    • Microarray-based
  • By Application Type
    • Infectious Diseases
      • HIV POC
      • Clostridium difficile POC
      • HBV POC
      • Pneumonia or Streptococcus associated infections
      • Respiratory syncytial virus (RSV) POC
      • HPV POC
      • Influenza/Flu POC
      • HCV POC
      • MRSA POC
      • TB and drug-resistant TB POC
      • HSV POC
      • Other Infectious Diseases
    • Oncology
    • Hematology
    • Prenatal Testing
    • Endocrinology
    • Other Applications
  • By Test Location
    • OTC
    • POC
  • By End Use
    • Decentralized Labs
    • Hospitals
    • Home-care
    • Assisted Living Healthcare Facilities
    • Others
  • By Region
  • North America
    • U.S
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Data Modelling
1.3.2.1. Company Share Analysis Model
1.3.2.2. Revenue Based Modelling
1.3.3. Phase III – Primary Research
1.3.4. Research Limitations
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global POC Molecular Diagnostics Market
2.2. Global POC Molecular Diagnostics Market, By Technology
2.3. Global POC Molecular Diagnostics Market, By Test Location
2.4. Global POC Molecular Diagnostics Market, By Application Type
2.5. Global POC Molecular Diagnostics Market, By End Use
2.6. Global POC Molecular Diagnostics Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global POC Molecular Diagnostics Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Technology
3.5.2. Test Location
3.5.3. Application Type
3.5.4. End Use
3.5.5. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Application Type
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Technology Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. InDirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Test Location Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global POC Molecular Diagnostics Market, By Technology
7.1. Global POC Molecular Diagnostics Market Overview, by Technology
7.1.1. Global POC Molecular Diagnostics Market Revenue Share, By Technology, 2022 Vs 2030 (in %)
7.2. PCR-based
7.2.1. Global POC Molecular Diagnostics Market, By Region, 2017-2030 (US$ Bn)
7.3. Genetic Sequencing-Based
7.3.1. Global POC Molecular Diagnostics Market, By Region, 2017-2030 (US$ Bn)
7.4. Hybridization-Based
7.4.1. Global POC Molecular Diagnostics Market, By Region, 2017-2030 (US$ Bn)
7.5. Microarray-Based
7.5.1. Global POC Molecular Diagnostics Market, By Region, 2017-2030 (US$ Bn)

8. Global POC Molecular Diagnostics Market, By Test Location
8.1. Global POC Molecular Diagnostics Market Overview, by Test Location
8.1.1. Global POC Molecular Diagnostics Market, By Test Location, 2022 vs 2030 (in %)
8.2. OTC
8.2.1. Global POC Molecular Diagnostics Market, By Region, 2017-2030 (US$ Bn)
8.3. POC
8.3.1. Global POC Molecular Diagnostics Market, By Region, 2017-2030 (US$ Bn)

9. Global POC Molecular Diagnostics Market, by Application Type, 2017-2030 (US$ Bn)
9.1. Global POC Molecular Diagnostics Market Overview, by Application Type
9.1.1. Global POC Molecular Diagnostics Market, By Application Type, 2022 vs 2030 (in%)
9.2. Infectious Diseases
9.2.1. Global POC Molecular Diagnostics Market, By Region, 2017-2030 (US$ Bn)
9.3. Oncology
9.3.1. Global POC Molecular Diagnostics Market, By Region, 2017-2030 (US$ Bn)
9.4. Hematology
9.4.1. Global POC Molecular Diagnostics Market, By Region, 2017-2030 (US$ Bn)
9.5. Prenatal Testing
9.5.1. Global POC Molecular Diagnostics Market, By Region, 2017-2030 (US$ Bn)
9.6. Endocrinology
9.6.1. Global POC Molecular Diagnostics Market, By Region, 2017-2030 (US$ Bn)
9.7. Other Applications
9.7.1. Global POC Molecular Diagnostics Market, By Region, 2017-2030 (US$ Bn)

10. Global POC Molecular Diagnostics Market, by End Use Type, 2017-2030 (US$ Bn)
10.1. Global POC Molecular Diagnostics Market Overview, by End Use
10.1.1. Global POC Molecular Diagnostics Market, By End Use, 2022 vs 2030 (in%)
10.2. Decentralized Labs
10.2.1. Global POC Molecular Diagnostics Market, By Region, 2017-2030 (US$ Bn)
10.3. Hospitals
10.3.1. Global POC Molecular Diagnostics Market, By Region, 2017-2030 (US$ Bn)
10.4. Home-Care
10.4.1. Global POC Molecular Diagnostics Market, By Region, 2017-2030 (US$ Bn)
10.5. Assisted Living Healthcare Facilities
10.5.1. Global POC Molecular Diagnostics Market, By Region, 2017-2030 (US$ Bn)
10.6. Others
10.6.1. Global POC Molecular Diagnostics Market, By Region, 2017-2030 (US$ Bn)

11. Global POC Molecular Diagnostics Market, By Region
11.1. Global POC Molecular Diagnostics Market Overview, by Region
11.1.1. Global POC Molecular Diagnostics Market, By Region, 2022 vs 2030 (in%)
11.2. Technology
11.2.1. Global POC Molecular Diagnostics Market, By Technology, 2017-2030 (US$ Bn)
11.3. Test Location
11.3.1. Global POC Molecular Diagnostics Market, By Test Location, 2017-2030 (US$ Bn)
11.4. End Use
11.4.1. Global POC Molecular Diagnostics Market, By End Use, 2017-2030 (US$ Bn)

12. North America POC Molecular Diagnostics Market Analysis
12.1. North America POC Molecular Diagnostics Market, by Technology, 2017-2030(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. North America POC Molecular Diagnostics Market, by Test Location, 2017-2030(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. North America POC Molecular Diagnostics Market, by Application Type, 2017-2030(US$ Bn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. North America POC Molecular Diagnostics Market, by End Use, 2017-2030(US$ Bn)
12.4.1. Overview
12.4.2. SRC Analysis
12.5. North America POC Molecular Diagnostics Market, by Country, 2017-2030 (US$ Bn)
12.5.1. North America POC Molecular Diagnostics Market, by Country, 2022 Vs 2030 (in%)
12.5.2. U.S.
12.5.2.1. U.S. POC Molecular Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.5.2.2. U.S. POC Molecular Diagnostics, By Technology, 2017-2030 (US$ Bn)
12.5.2.3. U.S. POC Molecular Diagnostics, By Test Location, 2017-2030 (US$ Bn)
12.5.2.4. U.S. POC Molecular Diagnostics, By Application Type, 2017-2030 (US$ Bn)
12.5.2.5. U.S. POC Molecular Diagnostics, By End Use, 2017-2030 (US$ Bn)
12.5.3. Canada
12.5.3.1. Canada POC Molecular Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.5.3.2. Canada POC Molecular Diagnostics, By Technology, 2017-2030 (US$ Bn)
12.5.3.3. Canada POC Molecular Diagnostics, By Test Location, 2017-2030 (US$ Bn)
12.5.3.4. Canada POC Molecular Diagnostics, By Application Type, 2017-2030 (US$ Bn)
12.5.3.5. Canada POC Molecular Diagnostics, By End Use, 2017-2030 (US$ Bn)
12.5.4. Mexico
12.5.4.1. Mexico POC Molecular Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.5.4.2. Mexico POC Molecular Diagnostics, By Technology, 2017-2030 (US$ Bn)
12.5.4.3. Mexico POC Molecular Diagnostics, By Test Location, 2017-2030 (US$ Bn)
12.5.4.4. Mexico POC Molecular Diagnostics, By Application Type, 2017-2030 (US$ Bn)
12.5.4.5. Mexico POC Molecular Diagnostics, By End Use, 2017-2030 (US$ Bn)

13. Europe POC Molecular Diagnostics Market Analysis
13.1. Europe POC Molecular Diagnostics Market, by Technology, 2017-2030(US$ Bn)
13.1.1. Overview
13.1.2. SRC Analysis
13.2. Europe POC Molecular Diagnostics Market, by Test Location, 2017-2030(US$ Bn)
13.2.1. Overview
13.2.2. SRC Analysis
13.3. Europe POC Molecular Diagnostics Market, by Application Type, 2017-2030(US$ Bn)
13.3.1. Overview
13.3.2. SRC Analysis
13.4. Europe POC Molecular Diagnostics Market, by End Use, 2017-2030(US$ Bn)
13.4.1. Overview
13.4.2. SRC Analysis
13.5. Europe POC Molecular Diagnostics Market, by Country, 2017-2030 (US$ Bn)
13.5.1. Europe POC Molecular Diagnostics Market, by Country, 2022 Vs 2030 (in%)
13.5.2. Germany
13.5.2.1. Germany POC Molecular Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.5.2.2. Germany POC Molecular Diagnostics, By Technology, 2017-2030 (US$ Bn)
13.5.2.3. Germany POC Molecular Diagnostics, By Test Location, 2017-2030 (US$ Bn)
13.5.2.4. Germany POC Molecular Diagnostics, By Application Type, 2017-2030 (US$ Bn)
13.5.2.5. Germany POC Molecular Diagnostics, By End Use, 2017-2030 (US$ Bn)
13.5.3. France
13.5.3.1. France POC Molecular Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.5.3.2. France POC Molecular Diagnostics, By Technology, 2017-2030 (US$ Bn)
13.5.3.3. France POC Molecular Diagnostics, By Test Location, 2017-2030 (US$ Bn)
13.5.3.4. Germany POC Molecular Diagnostics, By Application Type, 2017-2030 (US$ Bn)
13.5.3.5. Germany POC Molecular Diagnostics, By End Use, 2017-2030 (US$ Bn)
13.5.4. UK
13.5.4.1. UK POC Molecular Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.5.4.2. UK POC Molecular Diagnostics, By Technology, 2017-2030 (US$ Bn)
13.5.4.3. UK POC Molecular Diagnostics, By Test Location, 2017-2030 (US$ Bn)
13.5.4.4. UK POC Molecular Diagnostics, By Application Type, 2017-2030 (US$ Bn)
13.5.4.5. UK POC Molecular Diagnostics, By End Use, 2017-2030 (US$ Bn)
13.5.5. Italy
13.5.5.1. Italy POC Molecular Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.5.5.2. Italy POC Molecular Diagnostics, By Technology, 2017-2030 (US$ Bn)
13.5.5.3. Italy POC Molecular Diagnostics, By Test Location, 2017-2030 (US$ Bn)
13.5.5.4. Italy POC Molecular Diagnostics, By Application Type, 2017-2030 (US$ Bn)
13.5.5.5. Italy POC Molecular Diagnostics, By End Use, 2017-2030 (US$ Bn)
13.5.6. Spain
13.5.6.1. Spain POC Molecular Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.5.6.2. Spain POC Molecular Diagnostics, By Technology, 2017-2030 (US$ Bn)
13.5.6.3. Spain POC Molecular Diagnostics, By Test Location, 2017-2030 (US$ Bn)
13.5.6.4. Spain POC Molecular Diagnostics, By Application Type, 2017-2030 (US$ Bn)
13.5.6.5. Spain POC Molecular Diagnostics, By End Use, 2017-2030 (US$ Bn)
13.5.7. Rest of Europe
13.5.7.1. Rest of Europe POC Molecular Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
13.5.7.2. Rest of Europe POC Molecular Diagnostics, By Technology, 2017-2030 (US$ Bn)
13.5.7.3. Rest of Europe POC Molecular Diagnostics, By Test Location, 2017-2030 (US$ Bn)
13.5.7.4. Rest of Europe POC Molecular Diagnostics, By Application Type, 2017-2030 (US$ Bn)
13.5.7.5. Rest of Europe POC Molecular Diagnostics, By End Use, 2017-2030 (US$ Bn)

14. Asia Pacific POC Molecular Diagnostics Market Analysis
14.1. Asia Pacific POC Molecular Diagnostics Market, by Technology, 2017-2030(US$ Bn)
14.1.1. Overview
14.1.2. SRC Analysis
14.2. Asia Pacific POC Molecular Diagnostics Market, by Test Location, 2017-2030(US$ Bn)
14.2.1. Overview
14.2.2. SRC Analysis
14.3. Asia Pacific POC Molecular Diagnostics Market, by Application Type, 2017-2030(US$ Bn)
14.3.1. Overview
14.3.2. SRC Analysis
14.4. Asia Pacific POC Molecular Diagnostics Market, by End Use, 2017-2030(US$ Bn)
14.4.1. Overview
14.4.2. SRC Analysis
14.5. Asia Pacific POC Molecular Diagnostics Market, by Country, 2017-2030 (US$ Bn)
14.5.1. Asia Pacific POC Molecular Diagnostics Market, by Country, 2022 Vs 2030 (in%)
14.5.2. China
14.5.2.1. China POC Molecular Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.5.2.2. China POC Molecular Diagnostics, By Technology, 2017-2030 (US$ Bn)
14.5.2.3. China POC Molecular Diagnostics, By Test Location, 2017-2030 (US$ Bn)
14.5.2.4. China POC Molecular Diagnostics, By Application Type, 2017-2030 (US$ Bn)
14.5.2.5. China POC Molecular Diagnostics, By End Use, 2017-2030 (US$ Bn)
14.5.3. Japan
14.5.3.1. Japan POC Molecular Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.5.3.2. Japan POC Molecular Diagnostics, By Technology, 2017-2030 (US$ Bn)
14.5.3.3. Japan POC Molecular Diagnostics, By Test Location, 2017-2030 (US$ Bn)
14.5.3.4. Japan POC Molecular Diagnostics, By Application Type, 2017-2030 (US$ Bn)
14.5.3.5. Japan POC Molecular Diagnostics, By End Use, 2017-2030 (US$ Bn)
14.5.4. India
14.5.4.1. India POC Molecular Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.5.4.2. India POC Molecular Diagnostics, By Technology, 2017-2030 (US$ Bn)
14.5.4.3. India POC Molecular Diagnostics, By Test Location, 2017-2030 (US$ Bn)
14.5.4.4. India POC Molecular Diagnostics, By Application Type, 2017-2030 (US$ Bn)
14.5.4.5. India POC Molecular Diagnostics, By End Use, 2017-2030 (US$ Bn)
14.5.5. South Korea
14.5.5.1. South Korea POC Molecular Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.5.5.2. South Korea POC Molecular Diagnostics, By Technology, 2017-2030 (US$ Bn)
14.5.5.3. South Korea POC Molecular Diagnostics, By Test Location, 2017-2030 (US$ Bn)
14.5.5.4. South Korea POC Molecular Diagnostics, By Application Type, 2017-2030 (US$ Bn)
14.5.5.5. South Korea POC Molecular Diagnostics, By End Use, 2017-2030 (US$ Bn)
14.5.6. South-East Asia
14.5.6.1. South-East Asia POC Molecular Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.5.6.2. South-East Asia POC Molecular Diagnostics, By Technology, 2017-2030 (US$ Bn)
14.5.6.3. South-East Asia POC Molecular Diagnostics, By Test Location, 2017-2030 (US$ Bn)
14.5.6.4. South-East Asia POC Molecular Diagnostics, By Application Type, 2017-2030 (US$ Bn)
14.5.6.5. South-East Asia POC Molecular Diagnostics, By End Use, 2017-2030 (US$ Bn)
14.5.7. Rest of Asia Pacific
14.5.7.1. Rest of Asia Pacific POC Molecular Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
14.5.7.2. Rest of Asia Pacific POC Molecular Diagnostics, By Technology, 2017-2030 (US$ Bn)
14.5.7.3. Rest of Asia Pacific POC Molecular Diagnostics, By Test Location, 2017-2030 (US$ Bn)
14.5.7.4. Rest of Asia Pacific POC Molecular Diagnostics, By Application Type, 2017-2030 (US$ Bn)
14.5.7.5. Rest of Asia Pacific POC Molecular Diagnostics, By End Use, 2017-2030 (US$ Bn)

15. Latin America POC Molecular Diagnostics Market Analysis
15.1. Latin America POC Molecular Diagnostics Market, by Technology, 2017-2030(US$ Bn)
15.1.1. Overview
15.1.2. SRC Analysis
15.2. Latin America POC Molecular Diagnostics Market, by Test Location, 2017-2030(US$ Bn)
15.2.1. Overview
15.2.2. SRC Analysis
15.3. Latin America POC Molecular Diagnostics Market, by Application Type, 2017-2030(US$ Bn)
15.3.1. Overview
15.3.2. SRC Analysis
15.4. Latin America POC Molecular Diagnostics Market, by End Use, 2017-2030(US$ Bn)
15.4.1. Overview
15.4.2. SRC Analysis
15.5. Latin America POC Molecular Diagnostics Market, by Country, 2017-2030 (US$ Bn)
15.5.1. Latin America POC Molecular Diagnostics Market, by Country, 2022 Vs 2030 (in%)
15.5.2. Brazil
15.5.2.1. Brazil POC Molecular Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.5.2.2. Brazil POC Molecular Diagnostics, By Technology, 2017-2030 (US$ Bn)
15.5.2.3. Brazil POC Molecular Diagnostics, By Test Location, 2017-2030 (US$ Bn)
15.5.2.4. Brazil POC Molecular Diagnostics, By Application Type, 2017-2030 (US$ Bn)
15.5.2.5. Brazil POC Molecular Diagnostics, By End Use, 2017-2030 (US$ Bn)
15.5.3. Argentina
15.5.3.1. Argentina POC Molecular Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.5.3.2. Argentina POC Molecular Diagnostics, By Technology, 2017-2030 (US$ Bn)
15.5.3.3. Argentina POC Molecular Diagnostics, By Test Location, 2017-2030 (US$ Bn)
15.5.3.4. Argentina POC Molecular Diagnostics, By Application Type, 2017-2030 (US$ Bn)
15.5.3.5. Argentina POC Molecular Diagnostics, By End Use, 2017-2030 (US$ Bn)
15.5.4. Rest of Latin America
15.5.4.1. Rest of Latin America POC Molecular Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
15.5.4.2. Rest of Latin America POC Molecular Diagnostics, By Technology, 2017-2030 (US$ Bn)
15.5.4.3. Rest of Latin America POC Molecular Diagnostics, By Test Location, 2017-2030 (US$ Bn)
15.5.4.4. Rest of Latin America POC Molecular Diagnostics, By Application Type, 2017-2030 (US$ Bn)
15.5.4.5. Rest of Latin America POC Molecular Diagnostics, By End Use, 2017-2030 (US$ Bn)

16. Middle East and Africa POC Molecular Diagnostics Market Analysis
16.1. Middle East and Africa POC Molecular Diagnostics Market, by Technology, 2017-2030(US$ Bn)
16.1.1. Overview
16.1.2. SRC Analysis
16.2. Middle East and Africa POC Molecular Diagnostics Market, by Test Location, 2017-2030(US$ Bn)
16.2.1. Overview
16.2.2. SRC Analysis
16.3. Middle East and Africa POC Molecular Diagnostics Market, by Application Type, 2017-2030(US$ Bn)
16.3.1. Overview
16.3.2. SRC Analysis
16.4. Middle East and Africa POC Molecular Diagnostics Market, by End Use, 2017-2030(US$ Bn)
16.4.1. Overview
16.4.2. SRC Analysis
16.5. Middle East and Africa POC Molecular Diagnostics Market, by Country, 2017-2030 (US$ Bn)
16.5.1. Middle East and Africa POC Molecular Diagnostics Market, by Country, 2022 Vs 2030 (in%)
16.5.2. GCC Countries
16.5.2.1. GCC Countries POC Molecular Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
16.5.2.2. GCC Countries POC Molecular Diagnostics, By Technology, 2017-2030 (US$ Bn)
16.5.2.3. GCC Countries POC Molecular Diagnostics, By Test Location, 2017-2030 (US$ Bn)
16.5.2.4. GCC Countries POC Molecular Diagnostics, By Application Type, 2017-2030 (US$ Bn)
16.5.2.5. GCC Countries POC Molecular Diagnostics, By End Use, 2017-2030 (US$ Bn)
16.5.3. South Africa
16.5.3.1. South Africa POC Molecular Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
16.5.3.2. South Africa POC Molecular Diagnostics, By Technology, 2017-2030 (US$ Bn)
16.5.3.3. South Africa POC Molecular Diagnostics, By Test Location, 2017-2030 (US$ Bn)
16.5.3.4. South Africa POC Molecular Diagnostics, By Application Type, 2017-2030 (US$ Bn)
16.5.3.5. South Africa POC Molecular Diagnostics, By End Use, 2017-2030 (US$ Bn)
16.5.4. Rest of Middle East and Africa
16.5.4.1. Rest of Middle East and Africa POC Molecular Diagnostics Market Estimates and Forecast, 2017-2030 (US$ Bn)
16.5.4.2. Rest of Middle East and Africa POC Molecular Diagnostics, By Technology, 2017-2030 (US$ Bn)
16.5.4.3. Rest of Middle East and Africa POC Molecular Diagnostics, By Test Location, 2017-2030 (US$ Bn)
16.5.4.4. Rest of Middle East and Africa POC Molecular Diagnostics, By Application Type, 2017-2030 (US$ Bn)
16.5.4.5. Rest of Middle East and Africa POC Molecular Diagnostics, By End Use, 2017-2030 (US$ Bn)

17. Company Profiles
17.1. Abbott
17.1.1. Company Overview
17.1.2. Test Locations/Services Portfolio
17.1.3. Geographical Presence
17.1.4. Financial Summary
17.1.4.1. Market Revenue and Net Profit (2019-2022)
17.1.4.2. Business Segment Revenue Analysis
17.1.4.3. Geographical Revenue Analysis
17.2. Bayer AG
17.3. F. Hoffmann-La Roche AG
17.4. Nova Biomedical
17.5. QIAGEN
17.6. Nipro Diagnostics
17.7. Danaher
17.8. Bio-Rad Laboratories, Inc.
17.9. bioMérieux
17.10. Agilent Technologies, Inc.
17.11. Abaxis
17.12. OraSure Technologies

List of Figures
FIG. 1 Global POC Molecular Diagnostics Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global POC Molecular Diagnostics Market Segmentation
FIG. 4 Global POC Molecular Diagnostics Market, by Technology, 2022 (US$ Bn)
FIG. 5 Global POC Molecular Diagnostics Market, by Test Location, 2022 (US$ Bn)
FIG. 6 Global POC Molecular Diagnostics Market, by Application Type, 2022 (US$ Bn)
FIG. 7 Global POC Molecular Diagnostics Market, by End Use, 2022 (US$ Bn)
FIG. 8 Global POC Molecular Diagnostics Market, by Geography, 2022 (US$ Bn)
FIG. 9 Attractive Investment Proposition, by Technology, 2022
FIG. 10 Attractive Investment Proposition, by Test Location, 2022
FIG. 11 Attractive Investment Proposition, by Application Type, 2022
FIG. 12 Attractive Investment Proposition, by End Use, 2022
FIG. 13 Attractive Investment Proposition, by Geography, 2022
FIG. 14 Global Market Share Analysis of Key POC Molecular Diagnostics Market Manufacturers, 2022
FIG. 15 Global Market Positioning of Key POC Molecular Diagnostics Market Manufacturers, 2022
FIG. 16 Global POC Molecular Diagnostics Market Value Contribution, By Technology, 2022 & 2030 (Value %)
FIG. 17 Global POC Molecular Diagnostics Market, by PCR-based, Value, 2017-2030 (US$ Bn)
FIG. 18 Global POC Molecular Diagnostics Market, by Genetic Sequencing-Based, Value, 2017-2030 (US$ Bn)
FIG. 19 Global POC Molecular Diagnostics Market, by Hybridization-Based, Value, 2017-2030 (US$ Bn)
FIG. 20 Global POC Molecular Diagnostics Market, by Microarray-Based, Value, 2017-2030 (US$ Bn)
FIG. 21 Global POC Molecular Diagnostics Market Value Contribution, By Test Location, 2022 & 2030 (Value %)
FIG. 22 Global POC Molecular Diagnostics Market, by OTC, Value, 2017-2030 (US$ Bn)
FIG. 23 Global POC Molecular Diagnostics Market, by POC, 2017-2030 (US$ Bn)
FIG. 24 Global POC Molecular Diagnostics Market Value Contribution, By Application Type, 2022 & 2030 (Value %)
FIG. 25 Global POC Molecular Diagnostics Market, by Infectious Diseases, Value, 2017-2030 (US$ Bn)
FIG. 26 Global POC Molecular Diagnostics Market, by Oncology, 2017-2030 (US$ Bn)
FIG. 27 Global POC Molecular Diagnostics Market, by Hematology, 2017-2030 (US$ Bn)
FIG. 28 Global POC Molecular Diagnostics Market, by Prenatal Testing, 2017-2030 (US$ Bn)
FIG. 29 Global POC Molecular Diagnostics Market, by Endocrinology, 2017-2030 (US$ Bn)
FIG. 30 Global POC Molecular Diagnostics Market, by Other Applications, 2017-2030 (US$ Bn)
FIG. 31 Global POC Molecular Diagnostics Market Value Contribution, By End Use, 2022 & 2030 (Value %)
FIG. 32 Global POC Molecular Diagnostics Market, by Decentralized Labs, Value, 2017-2030 (US$ Bn)
FIG. 33 Global POC Molecular Diagnostics Market, by Hospitals, 2017-2030 (US$ Bn)
FIG. 34 Global POC Molecular Diagnostics Market, by Home-Care, Value, 2017-2030 (US$ Bn)
FIG. 35 Global POC Molecular Diagnostics Market, by Assisted Living Healthcare Facilities, 2017-2030 (US$ Bn)
FIG. 36 North America POC Molecular Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 37 U.S. POC Molecular Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 38 Canada POC Molecular Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 39 Europe POC Molecular Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 40 Germany POC Molecular Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 41 France POC Molecular Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 42 U.K. POC Molecular Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 43 Italy POC Molecular Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 44 Spain POC Molecular Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 45 Rest of Europe POC Molecular Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 46 Asia Pacific POC Molecular Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 47 China POC Molecular Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 48 Japan POC Molecular Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 49 India POC Molecular Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 50 South Korea POC Molecular Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 51 South-East Asia POC Molecular Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 52 Rest of Asia Pacific POC Molecular Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 53 Latin America POC Molecular Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 54 Brazil POC Molecular Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 55 Mexico POC Molecular Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 56 Rest of Latin America POC Molecular Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 57 Middle East & Africa POC Molecular Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 58 GCC Countries POC Molecular Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 59 South Africa POC Molecular Diagnostics Market, 2017-2030 (US$ Bn)
FIG. 60 Rest of Middle East and Africa POC Molecular Diagnostics Market, 2017-2030 (US$ Bn)

 

List of Tables
TABLE 1 Market Snapshot: Global POC Molecular Diagnostics Market
TABLE 2 Global POC Molecular Diagnostics Market: Market Application Typers Impact Analysis
TABLE 3 Global POC Molecular Diagnostics Market: Market Restraints Impact Analysis
TABLE 4 Global POC Molecular Diagnostics Market, by Competitive Benchmarking, 2022
TABLE 5 Global POC Molecular Diagnostics Market, by Geographical Presence Analysis, 2022
TABLE 6 Global POC Molecular Diagnostics Market, by Key Strategies Analysis, 2022
TABLE 7 Global POC Molecular Diagnostics Market, by PCR-based, By Region, 2017-2022 (US$ Bn)
TABLE 8 Global POC Molecular Diagnostics Market, by PCR-based, By Region, 2023-2030 (US$ Bn)
TABLE 9 Global POC Molecular Diagnostics Market, by Genetic Sequencing-Based, By Region, 2017-2022 (US$ Bn)
TABLE 10 Global POC Molecular Diagnostics Market, by Genetic Sequencing-Based, By Region, 2023-2030 (US$ Bn)
TABLE 11 Global POC Molecular Diagnostics Market, by Hybridization-Based, By Region, 2017-2022 (US$ Bn)
TABLE 12 Global POC Molecular Diagnostics Market, by Hybridization-Based, By Region, 2023-2030 (US$ Bn)
TABLE 13 Global POC Molecular Diagnostics Market, by Microarray-Based, By Region, 2017-2022 (US$ Bn)
TABLE 14 Global POC Molecular Diagnostics Market, by Microarray-Based, By Region, 2023-2030 (US$ Bn)
TABLE 15 Global POC Molecular Diagnostics Market, by OTC, By Region, 2017-2022 (US$ Bn)
TABLE 16 Global POC Molecular Diagnostics Market, by OTC, By Region, 2023-2030 (US$ Bn)
TABLE 17 Global POC Molecular Diagnostics Market, by POC, By Region, 2017-2022 (US$ Bn)
TABLE 18 Global POC Molecular Diagnostics Market, by POC, By Region, 2023-2030 (US$ Bn)
TABLE 19 Global POC Molecular Diagnostics Market, by Infectious Diseases, By Region, 2017-2022 (US$ Bn)
TABLE 20 Global POC Molecular Diagnostics Market, by Infectious Diseases, By Region, 2023-2030 (US$ Bn)
TABLE 21 Global POC Molecular Diagnostics Market, by Oncology, By Region, 2017-2022 (US$ Bn)
TABLE 22 Global POC Molecular Diagnostics Market, by Oncology, By Region, 2023-2030 (US$ Bn)
TABLE 23 Global POC Molecular Diagnostics Market, by Hematology, By Region, 2017-2022 (US$ Bn)
TABLE 24 Global POC Molecular Diagnostics Market, by Hematology, By Region, 2023-2030 (US$ Bn)
TABLE 25 Global POC Molecular Diagnostics Market, by Prenatal Testing, By Region, 2017-2022 (US$ Bn)
TABLE 26 Global POC Molecular Diagnostics Market, by Prenatal Testing, By Region, 2023-2030 (US$ Bn)
TABLE 27 Global POC Molecular Diagnostics Market, by Endocrinology, By Region, 2017-2022 (US$ Bn)
TABLE 28 Global POC Molecular Diagnostics Market, by Endocrinology, By Region, 2023-2030 (US$ Bn)
TABLE 29 Global POC Molecular Diagnostics Market, by Other Applications, By Region, 2017-2022 (US$ Bn)
TABLE 30 Global POC Molecular Diagnostics Market, by Other Applications, By Region, 2023-2030 (US$ Bn)
TABLE 31 Global POC Molecular Diagnostics Market, by Decentralized Labs, By Region, 2017-2022 (US$ Bn)
TABLE 32 Global POC Molecular Diagnostics Market, by Decentralized Labs, By Region, 2023-2030 (US$ Bn)
TABLE 33 Global POC Molecular Diagnostics Market, by Hospitals, By Region, 2017-2022 (US$ Bn)
TABLE 34 Global POC Molecular Diagnostics Market, by Hospitals, By Region, 2023-2030 (US$ Bn)
TABLE 35 Global POC Molecular Diagnostics Market, by Home-Care, By Region, 2017-2022 (US$ Bn)
TABLE 36 Global POC Molecular Diagnostics Market, by Home-Care, By Region, 2023-2030 (US$ Bn)
TABLE 37 Global POC Molecular Diagnostics Market, by Technology, 2017-2022 (US$ Bn)
TABLE 38 Global POC Molecular Diagnostics Market, by Technology, 2017-2022 (US$ Bn)
TABLE 39 Global POC Molecular Diagnostics Market, by Test Location, 2017-2022 (US$ Bn)
TABLE 40 Global POC Molecular Diagnostics Market, by Test Location, 2023-2030 (US$ Bn)
TABLE 41 Global POC Molecular Diagnostics Market, by Application Type, 2017-2022 (US$ Bn)
TABLE 42 Global POC Molecular Diagnostics Market, by Application Type, 2023-2030 (US$ Bn)
TABLE 43 Global POC Molecular Diagnostics Market, by End Use, 2017-2022 (US$ Bn)
TABLE 44 Global POC Molecular Diagnostics Market, by End Use, 2023-2030 (US$ Bn)
TABLE 45 Global POC Molecular Diagnostics Market, by Region, 2017-2022 (US$ Bn)
TABLE 46 Global POC Molecular Diagnostics Market, by Region, 2023-2030 (US$ Bn)
TABLE 47 North America POC Molecular Diagnostics Market, by Technology, 2017-2022 (US$ Bn)
TABLE 48 North America POC Molecular Diagnostics Market, by Technology, 2023-2030 (US$ Bn)
TABLE 49 North America POC Molecular Diagnostics Market, by Test Location, 2017-2022 (US$ Bn)
TABLE 50 North America POC Molecular Diagnostics Market, by Test Location, 2023-2030 (US$ Bn)
TABLE 51 North America POC Molecular Diagnostics Market, by Application Type, 2017-2022 (US$ Bn)
TABLE 52 North America POC Molecular Diagnostics Market, by Application Type, 2023-2030 (US$ Bn)
TABLE 53 North America POC Molecular Diagnostics Market, by End Use, 2023-2030 (US$ Bn)
TABLE 54 North America POC Molecular Diagnostics Market, by End Use, 2017-2022 (US$ Bn)
TABLE 55 North America POC Molecular Diagnostics Market, by End Use, 2023-2030 (US$ Bn)
TABLE 56 North America POC Molecular Diagnostics Market, by Country, 2017-2022 (US$ Bn)
TABLE 57 North America POC Molecular Diagnostics Market, by Country, 2023-2030 (US$ Bn)
TABLE 58 United States POC Molecular Diagnostics Market, by Technology, 2017-2022 (US$ Bn)
TABLE 59 United States POC Molecular Diagnostics Market, by Technology, 2023-2030 (US$ Bn)
TABLE 60 United States POC Molecular Diagnostics Market, by Test Location, 2017-2022 (US$ Bn)
TABLE 61 United States POC Molecular Diagnostics Market, by Test Location, 2023-2030 (US$ Bn)
TABLE 62 United States POC Molecular Diagnostics Market, by Application Type, 2017-2022 (US$ Bn)
TABLE 63 United States POC Molecular Diagnostics Market, by Application Type, 2023-2030 (US$ Bn)
TABLE 64 United States POC Molecular Diagnostics Market, by End Use, 2017-2022 (US$ Bn)
TABLE 65 United States POC Molecular Diagnostics Market, by End Use, 2023-2030 (US$ Bn)
TABLE 66 Canada POC Molecular Diagnostics Market, by Technology, 2017-2022 (US$ Bn)
TABLE 67 Canada POC Molecular Diagnostics Market, by Technology, 2023-2030 (US$ Bn)
TABLE 68 Canada POC Molecular Diagnostics Market, by Test Location, 2017-2022 (US$ Bn)
TABLE 69 Canada POC Molecular Diagnostics Market, by Test Location, 2023-2030 (US$ Bn)
TABLE 70 Canada POC Molecular Diagnostics Market, by Application Type, 2017-2022 (US$ Bn)
TABLE 71 Canada POC Molecular Diagnostics Market, by Application Type, 2023-2030 (US$ Bn)
TABLE 72 Canada POC Molecular Diagnostics Market, by End Use, 2017-2022 (US$ Bn)
TABLE 73 Canada POC Molecular Diagnostics Market, by End Use, 2023-2030 (US$ Bn)
TABLE 74 Mexico POC Molecular Diagnostics Market, by Technology, 2017-2022 (US$ Bn)
TABLE 75 Mexico POC Molecular Diagnostics Market, by Technology, 2023-2030 (US$ Bn)
TABLE 76 Mexico POC Molecular Diagnostics Market, by Test Location, 2017-2022 (US$ Bn)
TABLE 77 Mexico POC Molecular Diagnostics Market, by Test Location, 2023-2030 (US$ Bn)
TABLE 78 Mexico POC Molecular Diagnostics Market, by Application Type, 2017-2022 (US$ Bn)
TABLE 79 Mexico POC Molecular Diagnostics Market, by Application Type, 2023-2030 (US$ Bn)
TABLE 80 Mexico POC Molecular Diagnostics Market, by End Use, 2017-2022 (US$ Bn)
TABLE 81 Mexico POC Molecular Diagnostics Market, by End Use, 2023-2030 (US$ Bn)
TABLE 82 Europe POC Molecular Diagnostics Market, by Technology, 2017-2022 (US$ Bn)
TABLE 83 Europe POC Molecular Diagnostics Market, by Technology, 2023-2030 (US$ Bn)
TABLE 84 Europe POC Molecular Diagnostics Market, by Test Location, 2017-2022 (US$ Bn)
TABLE 85 Europe POC Molecular Diagnostics Market, by Test Location, 2023-2030 (US$ Bn)
TABLE 86 Europe POC Molecular Diagnostics Market, by Application Type, 2017-2022 (US$ Bn)
TABLE 87 Europe POC Molecular Diagnostics Market, by Application Type, 2023-2030 (US$ Bn)
TABLE 88 Europe POC Molecular Diagnostics Market, by End Use, 2017-2022 (US$ Bn)
TABLE 89 Europe POC Molecular Diagnostics Market, by End Use, 2023-2030 (US$ Bn)
TABLE 90 Europe POC Molecular Diagnostics Market, by Country, 2017-2022 (US$ Bn)
TABLE 91 Europe POC Molecular Diagnostics Market, by Country, 2023-2030 (US$ Bn)
TABLE 92 Germany POC Molecular Diagnostics Market, by Technology, 2017-2022 (US$ Bn)
TABLE 93 Germany POC Molecular Diagnostics Market, by Technology, 2023-2030 (US$ Bn)
TABLE 94 Germany POC Molecular Diagnostics Market, by Test Location, 2017-2022 (US$ Bn)
TABLE 95 Germany POC Molecular Diagnostics Market, by Test Location, 2023-2030 (US$ Bn)
TABLE 96 Germany POC Molecular Diagnostics Market, by Application Type, 2017-2022 (US$ Bn)
TABLE 97 Germany POC Molecular Diagnostics Market, by Application Type, 2023-2030 (US$ Bn)
TABLE 98 Germany POC Molecular Diagnostics Market, by End Use, 2017-2022 (US$ Bn)
TABLE 99 Germany POC Molecular Diagnostics Market, by End Use, 2023-2030 (US$ Bn)
TABLE 100 France POC Molecular Diagnostics Market, by Technology, 2017-2022 (US$ Bn)
TABLE 101 France POC Molecular Diagnostics Market, by Technology, 2023-2030 (US$ Bn)
TABLE 102 France POC Molecular Diagnostics Market, by Test Location, 2017-2022 (US$ Bn)
TABLE 103 France POC Molecular Diagnostics Market, by Test Location, 2023-2030 (US$ Bn)
TABLE 104 France POC Molecular Diagnostics Market, by Application Type, 2017-2022 (US$ Bn)
TABLE 105 France POC Molecular Diagnostics Market, by Application Type, 2023-2030 (US$ Bn)
TABLE 106 France POC Molecular Diagnostics Market, by End Use, 2017-2022 (US$ Bn)
TABLE 107 France POC Molecular Diagnostics Market, by End Use, 2023-2030 (US$ Bn)
TABLE 108 United Kingdom POC Molecular Diagnostics Market, by Technology, 2017-2022 (US$ Bn)
TABLE 109 United Kingdom POC Molecular Diagnostics Market, by Technology, 2023-2030 (US$ Bn)
TABLE 110 United Kingdom POC Molecular Diagnostics Market, by Test Location, 2017-2022 (US$ Bn)
TABLE 111 United Kingdom POC Molecular Diagnostics Market, by Test Location, 2023-2030 (US$ Bn)
TABLE 112 United Kingdom POC Molecular Diagnostics Market, by Application Type, 2017-2022 (US$ Bn)
TABLE 113 United Kingdom POC Molecular Diagnostics Market, by Application Type, 2023-2030 (US$ Bn)
TABLE 114 United Kingdom POC Molecular Diagnostics Market, by End Use, 2017-2022 (US$ Bn)
TABLE 115 United Kingdom POC Molecular Diagnostics Market, by End Use, 2023-2030 (US$ Bn)
TABLE 116 Italy POC Molecular Diagnostics Market, by Technology, 2017-2022 (US$ Bn)
TABLE 117 Italy POC Molecular Diagnostics Market, by Technology, 2023-2030 (US$ Bn)
TABLE 118 Italy POC Molecular Diagnostics Market, by Test Location, 2017-2022 (US$ Bn)
TABLE 119 Italy POC Molecular Diagnostics Market, by Test Location, 2023-2030 (US$ Bn)
TABLE 120 Italy POC Molecular Diagnostics Market, by Application Type, 2017-2022 (US$ Bn)
TABLE 121 Italy POC Molecular Diagnostics Market, by Application Type, 2023-2030 (US$ Bn)
TABLE 122 Italy POC Molecular Diagnostics Market, by End Use, 2017-2022 (US$ Bn)
TABLE 123 Italy POC Molecular Diagnostics Market, by End Use, 2023-2030 (US$ Bn)
TABLE 124 Spain POC Molecular Diagnostics Market, by Technology, 2017-2022 (US$ Bn)
TABLE 125 Spain POC Molecular Diagnostics Market, by Technology, 2023-2030 (US$ Bn)
TABLE 126 Spain POC Molecular Diagnostics Market, by Test Location, 2017-2022 (US$ Bn)
TABLE 127 Spain POC Molecular Diagnostics Market, by Test Location, 2023-2030 (US$ Bn)
TABLE 128 Spain POC Molecular Diagnostics Market, by Application Type, 2017-2022 (US$ Bn)
TABLE 129 Spain POC Molecular Diagnostics Market, by Application Type, 2023-2030 (US$ Bn)
TABLE 130 Spain POC Molecular Diagnostics Market, by End Use, 2017-2022 (US$ Bn)
TABLE 131 Spain POC Molecular Diagnostics Market, by End Use, 2023-2030 (US$ Bn)
TABLE 132 Rest of Europe POC Molecular Diagnostics Market, by Technology, 2017-2022 (US$ Bn)
TABLE 133 Rest of Europe POC Molecular Diagnostics Market, by Technology, 2023-2030 (US$ Bn)
TABLE 134 Rest of Europe POC Molecular Diagnostics Market, by Test Location, 2017-2022 (US$ Bn)
TABLE 135 Rest of Europe POC Molecular Diagnostics Market, by Test Location, 2023-2030 (US$ Bn)
TABLE 136 Rest of Europe POC Molecular Diagnostics Market, by Application Type, 2017-2022 (US$ Bn)
TABLE 137 Rest of Europe POC Molecular Diagnostics Market, by Application Type, 2023-2030 (US$ Bn)
TABLE 138 Rest of Europe POC Molecular Diagnostics Market, by End Use, 2017-2022 (US$ Bn)
TABLE 139 Rest of Europe POC Molecular Diagnostics Market, by End Use, 2023-2030 (US$ Bn)
TABLE 140 Asia Pacific POC Molecular Diagnostics Market, by Technology, 2017-2022 (US$ Bn)
TABLE 141 Asia Pacific POC Molecular Diagnostics Market, by Technology, 2023-2030 (US$ Bn)
TABLE 142 Asia Pacific POC Molecular Diagnostics Market, by Test Location, 2017-2022 (US$ Bn)
TABLE 143 Asia Pacific POC Molecular Diagnostics Market, by Test Location, 2023-2030 (US$ Bn)
TABLE 144 Asia Pacific POC Molecular Diagnostics Market, by Application Type, 2017-2022 (US$ Bn)
TABLE 145 Asia Pacific POC Molecular Diagnostics Market, by Application Type, 2023-2030 (US$ Bn)
TABLE 146 Asia Pacific POC Molecular Diagnostics Market, by End Use, 2017-2022 (US$ Bn)
TABLE 147 Asia Pacific POC Molecular Diagnostics Market, by End Use, 2023-2030 (US$ Bn)
TABLE 148 China POC Molecular Diagnostics Market, by Technology, 2017-2022 (US$ Bn)
TABLE 149 China POC Molecular Diagnostics Market, by Technology, 2023-2030 (US$ Bn)
TABLE 150 China POC Molecular Diagnostics Market, by Test Location, 2017-2022 (US$ Bn)
TABLE 151 China POC Molecular Diagnostics Market, by Test Location, 2023-2030 (US$ Bn)
TABLE 152 China POC Molecular Diagnostics Market, by Application Type, 2017-2022 (US$ Bn)
TABLE 153 China POC Molecular Diagnostics Market, by Application Type, 2023-2030 (US$ Bn)
TABLE 154 China POC Molecular Diagnostics Market, by End Use, 2017-2022 (US$ Bn)
TABLE 155 China POC Molecular Diagnostics Market, by End Use, 2023-2030 (US$ Bn)
TABLE 156 Japan POC Molecular Diagnostics Market, by Technology, 2017-2022 (US$ Bn)
TABLE 157 Japan POC Molecular Diagnostics Market, by Technology, 2023-2030 (US$ Bn)
TABLE 158 Japan POC Molecular Diagnostics Market, by Test Location, 2017-2022 (US$ Bn)
TABLE 159 Japan POC Molecular Diagnostics Market, by Test Location, 2023-2030 (US$ Bn)
TABLE 160 Japan POC Molecular Diagnostics Market, by Application Type, 2017-2022 (US$ Bn)
TABLE 161 Japan POC Molecular Diagnostics Market, by Application Type, 2023-2030 (US$ Bn)
TABLE 162 Japan POC Molecular Diagnostics Market, by End Use, 2017-2022 (US$ Bn)
TABLE 163 Japan POC Molecular Diagnostics Market, by End Use, 2023-2030 (US$ Bn)
TABLE 164 India POC Molecular Diagnostics Market, by Technology, 2017-2022 (US$ Bn)
TABLE 165 India POC Molecular Diagnostics Market, by Technology, 2023-2030 (US$ Bn)
TABLE 166 India POC Molecular Diagnostics Market, by Test Location, 2017-2022 (US$ Bn)
TABLE 167 India POC Molecular Diagnostics Market, by Test Location, 2023-2030 (US$ Bn)
TABLE 168 India POC Molecular Diagnostics Market, by Application Type, 2017-2022 (US$ Bn)
TABLE 169 India POC Molecular Diagnostics Market, by Application Type, 2023-2030 (US$ Bn)
TABLE 170 India POC Molecular Diagnostics Market, by End Use, 2017-2022 (US$ Bn)
TABLE 171 India POC Molecular Diagnostics Market, by End Use, 2023-2030 (US$ Bn)
TABLE 172 South Korea POC Molecular Diagnostics Market, by Technology, 2017-2022 (US$ Bn)
TABLE 173 South Korea POC Molecular Diagnostics Market, by Technology, 2023-2030 (US$ Bn)
TABLE 174 South Korea POC Molecular Diagnostics Market, by Test Location, 2017-2022 (US$ Bn)
TABLE 175 South Korea POC Molecular Diagnostics Market, by Test Location, 2023-2030 (US$ Bn)
TABLE 176 South Korea POC Molecular Diagnostics Market, by Application Type, 2017-2022 (US$ Bn)
TABLE 177 South Korea POC Molecular Diagnostics Market, by Application Type, 2023-2030 (US$ Bn)
TABLE 178 South Korea POC Molecular Diagnostics Market, by End Use, 2017-2022 (US$ Bn)
TABLE 179 South Korea POC Molecular Diagnostics Market, by End Use, 2023-2030 (US$ Bn)
TABLE 180 South-East Asia POC Molecular Diagnostics Market, by Technology, 2017-2022 (US$ Bn)
TABLE 181 South-East Asia POC Molecular Diagnostics Market, by Technology, 2023-2030 (US$ Bn)
TABLE 182 South-East Asia POC Molecular Diagnostics Market, by Test Location, 2017-2022 (US$ Bn)
TABLE 183 South-East Asia POC Molecular Diagnostics Market, by Test Location, 2023-2030 (US$ Bn)
TABLE 184 South-East Asia POC Molecular Diagnostics Market, by Application Type, 2017-2022 (US$ Bn)
TABLE 185 South-East Asia POC Molecular Diagnostics Market, by Application Type, 2023-2030 (US$ Bn)
TABLE 186 South-East Asia POC Molecular Diagnostics Market, by End Use, 2017-2022 (US$ Bn)
TABLE 187 South-East Asia POC Molecular Diagnostics Market, by End Use, 2023-2030 (US$ Bn)
TABLE 188 Rest of Asia Pacific POC Molecular Diagnostics Market, by Technology, 2017-2022 (US$ Bn)
TABLE 189 Rest of Asia Pacific POC Molecular Diagnostics Market, by Technology, 2023-2030 (US$ Bn)
TABLE 190 Rest of Asia Pacific POC Molecular Diagnostics Market, by Test Location, 2017-2022 (US$ Bn)
TABLE 191 Rest of Asia Pacific POC Molecular Diagnostics Market, by Test Location, 2023-2030 (US$ Bn)
TABLE 192 Rest of Asia Pacific POC Molecular Diagnostics Market, by Application Type, 2017-2022 (US$ Bn)
TABLE 193 Rest of Asia Pacific POC Molecular Diagnostics Market, by Application Type, 2023-2030 (US$ Bn)
TABLE 194 Rest of Asia Pacific POC Molecular Diagnostics Market, by End Use, 2017-2022 (US$ Bn)
TABLE 195 Rest of Asia Pacific POC Molecular Diagnostics Market, by End Use, 2023-2030 (US$ Bn)
TABLE 196 Latin America POC Molecular Diagnostics Market, by Technology, 2017-2022 (US$ Bn)
TABLE 197 Latin America POC Molecular Diagnostics Market, by Technology, 2023-2030 (US$ Bn)
TABLE 198 Latin America POC Molecular Diagnostics Market, by Test Location, 2017-2022 (US$ Bn)
TABLE 199 Latin America POC Molecular Diagnostics Market, by Test Location, 2023-2030 (US$ Bn)
TABLE 200 Latin America POC Molecular Diagnostics Market, by Application Type, 2017-2022 (US$ Bn)
TABLE 201 Latin America POC Molecular Diagnostics Market, by Application Type, 2023-2030 (US$ Bn)
TABLE 202 Latin America POC Molecular Diagnostics Market, by End Use, 2017-2022 (US$ Bn)
TABLE 203 Latin America POC Molecular Diagnostics Market, by End Use, 2023-2030 (US$ Bn)
TABLE 204 Brazil POC Molecular Diagnostics Market, by Technology, 2017-2022 (US$ Bn)
TABLE 205 Brazil POC Molecular Diagnostics Market, by Technology, 2023-2030 (US$ Bn)
TABLE 206 Brazil POC Molecular Diagnostics Market, by Test Location, 2017-2022 (US$ Bn)
TABLE 207 Brazil POC Molecular Diagnostics Market, by Test Location, 2023-2030 (US$ Bn)
TABLE 208 Brazil POC Molecular Diagnostics Market, by Application Type, 2017-2022 (US$ Bn)
TABLE 209 Brazil POC Molecular Diagnostics Market, by Application Type, 2023-2030 (US$ Bn)
TABLE 210 Brazil POC Molecular Diagnostics Market, by End Use, 2017-2022 (US$ Bn)
TABLE 211 Brazil POC Molecular Diagnostics Market, by End Use, 2023-2030 (US$ Bn)
TABLE 212 Argentina POC Molecular Diagnostics Market, by Technology, 2017-2022 (US$ Bn)
TABLE 213 Argentina POC Molecular Diagnostics Market, by Technology, 2023-2030 (US$ Bn)
TABLE 214 Argentina POC Molecular Diagnostics Market, by Test Location, 2017-2022 (US$ Bn)
TABLE 215 Argentina POC Molecular Diagnostics Market, by Test Location, 2023-2030 (US$ Bn)
TABLE 216 Argentina POC Molecular Diagnostics Market, by Application Type, 2017-2022 (US$ Bn)
TABLE 217 Argentina POC Molecular Diagnostics Market, by Application Type, 2023-2030 (US$ Bn)
TABLE 218 Argentina POC Molecular Diagnostics Market, by End Use, 2017-2022 (US$ Bn)
TABLE 219 Argentina POC Molecular Diagnostics Market, by End Use, 2023-2030 (US$ Bn)
TABLE 220 Rest of Latin America POC Molecular Diagnostics Market, by Technology, 2017-2022 (US$ Bn)
TABLE 221 Rest of Latin America POC Molecular Diagnostics Market, by Technology, 2023-2030 (US$ Bn)
TABLE 222 Rest of Latin America POC Molecular Diagnostics Market, by Test Location, 2017-2022 (US$ Bn)
TABLE 223 Rest of Latin America POC Molecular Diagnostics Market, by Test Location, 2023-2030 (US$ Bn)
TABLE 224 Rest of Latin America POC Molecular Diagnostics Market, by Application Type, 2017-2022 (US$ Bn)
TABLE 225 Rest of Latin America POC Molecular Diagnostics Market, by Application Type, 2023-2030 (US$ Bn)
TABLE 226 Rest of Latin America POC Molecular Diagnostics Market, by End Use, 2017-2022 (US$ Bn)
TABLE 227 Rest of Latin America POC Molecular Diagnostics Market, by End Use, 2023-2030 (US$ Bn)
TABLE 228 Middle East and Africa POC Molecular Diagnostics Market, by Technology, 2017-2022 (US$ Bn)
TABLE 229 Middle East and Africa POC Molecular Diagnostics Market, by Technology, 2023-2030 (US$ Bn)
TABLE 230 Middle East and Africa POC Molecular Diagnostics Market, by Test Location, 2017-2022 (US$ Bn)
TABLE 231 Middle East and Africa POC Molecular Diagnostics Market, by Test Location, 2023-2030 (US$ Bn)
TABLE 232 Middle East and Africa POC Molecular Diagnostics Market, by Application Type, 2017-2022 (US$ Bn)
TABLE 233 Middle East and Africa POC Molecular Diagnostics Market, by Application Type, 2023-2030 (US$ Bn)
TABLE 234 Middle East and Africa POC Molecular Diagnostics Market, by End Use, 2017-2022 (US$ Bn)
TABLE 235 Middle East and Africa POC Molecular Diagnostics Market, by End Use, 2023-2030 (US$ Bn)
TABLE 236 GCC Countries POC Molecular Diagnostics Market, by Technology, 2017-2022 (US$ Bn)
TABLE 237 GCC Countries POC Molecular Diagnostics Market, by Technology, 2023-2030 (US$ Bn)
TABLE 238 GCC Countries POC Molecular Diagnostics Market, by Test Location, 2017-2022 (US$ Bn)
TABLE 239 GCC Countries POC Molecular Diagnostics Market, by Test Location, 2023-2030 (US$ Bn)
TABLE 240 GCC Countries POC Molecular Diagnostics Market, by Application Type, 2017-2022 (US$ Bn)
TABLE 241 GCC Countries POC Molecular Diagnostics Market, by Application Type, 2023-2030 (US$ Bn)
TABLE 242 GCC Countries POC Molecular Diagnostics Market, by End Use, 2017-2022 (US$ Bn)
TABLE 243 GCC Countries POC Molecular Diagnostics Market, by End Use, 2023-2030 (US$ Bn)
TABLE 244 South Africa POC Molecular Diagnostics Market, by Technology, 2017-2022 (US$ Bn)
TABLE 245 South Africa POC Molecular Diagnostics Market, by Technology, 2023-2030 (US$ Bn)
TABLE 246 South Africa POC Molecular Diagnostics Market, by Test Location, 2017-2022 (US$ Bn)
TABLE 247 South Africa POC Molecular Diagnostics Market, by Test Location, 2023-2030 (US$ Bn)
TABLE 248 South Africa POC Molecular Diagnostics Market, by Application Type, 2017-2022 (US$ Bn)
TABLE 249 South Africa POC Molecular Diagnostics Market, by Application Type, 2023-2030 (US$ Bn)
TABLE 250 South Africa POC Molecular Diagnostics Market, by End Use, 2017-2022 (US$ Bn)
TABLE 251 South Africa POC Molecular Diagnostics Market, by End Use, 2023-2030 (US$ Bn)
TABLE 252 Rest of Middle East and Africa POC Molecular Diagnostics Market, by Technology, 2017-2022 (US$ Bn)
TABLE 253 Rest of Middle East and Africa POC Molecular Diagnostics Market, by Technology, 2023-2030 (US$ Bn)
TABLE 254 Rest of Middle East and Africa POC Molecular Diagnostics Market, by Test Location, 2017-2022 (US$ Bn)
TABLE 255 Rest of Middle East and Africa POC Molecular Diagnostics Market, by Test Location, 2023-2030 (US$ Bn)
TABLE 256 Rest of Middle East and Africa POC Molecular Diagnostics Market, by Application Type, 2017-2022 (US$ Bn)
TABLE 257 Rest of Middle East and Africa POC Molecular Diagnostics Market, by Application Type, 2023-2030 (US$ Bn)
TABLE 258 Rest of Middle East and Africa POC Molecular Diagnostics Market, by End Use, 2017-2022 (US$ Bn)
TABLE 259 Rest of Middle East and Africa POC Molecular Diagnostics Market, by End Use, 2023-2030 (US$ Bn)

Frequently Asked Questions

What is the current size of the global POC molecular diagnostics market?

The global POC molecular diagnostics market was valued at USD 6.9 Billion in 2022.

What is the expected growth rate of the POC molecular diagnostics market between 2023 and 2030?

The POC molecular diagnostics market is expected to grow at a CAGR of 3.3% between 2023 and 2030, reaching USD 8.6 Billion in 2030.

Which segment is leading the market share in terms of technology?

PCR-based is the leading segment by technology, holding over 30% share in value in 2022.

Which application type segment governs the demand for POC molecular diagnostics worldwide?

Infectious diseases govern the global demand for POC molecular diagnostics, holding a massive share of over 50% in 2022.

Which test location  segment governs the demand for POC molecular diagnostics worldwide?

The POC segment is expected to post the highest CAGR during the forecast period.

Which region is fueling the growth of the POC molecular diagnostics industry?

North America is fueling the growth of the POC molecular diagnostics industry, with an over one-third share in 2022.

Who are the major players in the global POC molecular diagnostics market?

The top players include Abbott, Bayer AG, F. Hoffmann-La Roche AG, Nova Biomedical, and QIAGEN.

What are the major market drivers of the POC molecular diagnostics industry?

The major market drivers are increasing demand for rapid and accurate diagnostic testing, rising prevalence of infectious diseases, advancements in digital health technologies, and growing need for early detection and personalized medicine.

What are the major market restraints of the POC molecular diagnostics industry?

The major market restraints include a complex regulatory landscape, stringent quality standards, and high cost associated with developing and implementing POC molecular diagnostics.

What are the major market opportunities of the POC molecular diagnostics industry?

Expansion into emerging markets with growing healthcare infrastructure, integration of POC molecular diagnostics with digital health technologies, and development of cost-effective and user-friendly POC molecular diagnostic solutions.

Cervical Total Disc Replacement Market

Published:
Report ID: 36030

Aseptic Sampling Market

Published:
Report ID: 36018

Capillary Blood Collection Devices Market

Published:
Report ID: 36014

Contrast Media Market

Published:
Report ID: 36005

Medical Adhesive Tapes Market

Published:
Report ID: 35998

OTC Vitamins Dietary Supplements Market

Published:
Report ID: 35994

Tooth Filling Materials Market

Published:
Report ID: 35987

US Retail Pharmacy Market

Published:
Report ID: 32801

Nanomedicine Therapeutics Market

Published:
Report ID: 35961

Liposomes Market

Published:
Report ID: 35888

Triple Negative Breast Cancer Market

Published:
Report ID: 35843

Colorectal Cancer Screening and Diagnostic Market

Published:
Report ID: 35780

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN